Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Kay

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Journal of the Reticuloendothelial Society|October 1, 1980
Effects of 2-deoxy-D-glucose on human monocyte metabolism and functionN E Kay, T F Bumol, S D Douglas
Annals of Internal Medicine|August 1, 1981
Severe zinc deficiency in humans: association with a reversible T-lymphocyte dysfunctionJ I Allen, N E Kay, C J McClain
International Journal of Cancer|March 15, 1981
Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemiaH W Ziegler, N E Kay, J M Zarling
Surgical Neurology|October 1, 1977
Neutrophil chemotaxis in cerebral astrocytomaN E Kay, K J Murray, S D Douglas
Clinical Immunology and Immunopathology|July 1, 1979
Detachment of adherent human monocytes from glass surfaces induced by antibody-coated and uncoated erythrocytesN E Kay, S K Ackerman, S D Douglas
Cellular Immunology|November 1, 1980
Effect of adenosine deaminase inhibitors on Fc mu receptor expression in human T-cell culturesS H Zuckerman, N E Kay, S D Douglas
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantiseraB S Wilson, N E Kay, K Imai, et al.
British Journal of Haematology|June 1, 1993
Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL cloneN E Kay, R Suen, E Ranheim, et al.
Blood|August 1, 1988
The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptorsN E Kay, J Burton, D Wagner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1986
The monoclonal antibody CJA3 down-regulates the susceptibility of human tumor cell lines to natural cell-mediated cytotoxicityJ I Allen, S Ferrone, D Boue, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Journal of the Reticuloendothelial Society|October 1, 1980
Effects of 2-deoxy-D-glucose on human monocyte metabolism and functionN E Kay, T F Bumol, S D Douglas
Annals of Internal Medicine|August 1, 1981
Severe zinc deficiency in humans: association with a reversible T-lymphocyte dysfunctionJ I Allen, N E Kay, C J McClain
International Journal of Cancer|March 15, 1981
Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemiaH W Ziegler, N E Kay, J M Zarling
Surgical Neurology|October 1, 1977
Neutrophil chemotaxis in cerebral astrocytomaN E Kay, K J Murray, S D Douglas
Clinical Immunology and Immunopathology|July 1, 1979
Detachment of adherent human monocytes from glass surfaces induced by antibody-coated and uncoated erythrocytesN E Kay, S K Ackerman, S D Douglas
Cellular Immunology|November 1, 1980
Effect of adenosine deaminase inhibitors on Fc mu receptor expression in human T-cell culturesS H Zuckerman, N E Kay, S D Douglas
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantiseraB S Wilson, N E Kay, K Imai, et al.
British Journal of Haematology|June 1, 1993
Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL cloneN E Kay, R Suen, E Ranheim, et al.
Blood|August 1, 1988
The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptorsN E Kay, J Burton, D Wagner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1986
The monoclonal antibody CJA3 down-regulates the susceptibility of human tumor cell lines to natural cell-mediated cytotoxicityJ I Allen, S Ferrone, D Boue, et al.
Pageof 15